FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like Inaugural Asia Pacific GAMP Data Integrity Conference Announced July 16, 2017 iCAD Wins FDA Approval for PowerLook Tomo Detection March 26, 2017 Bay Area Galena Biopharma Merges With Oncology-Focused Biopharma in All-Stock Deal August 7, 2017
